Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of currently used drugs represent major barriers that need to be overcome to provide a viable cure. Nanomedicines (NMeds)...
Saved in:
Main Authors: | Jason Thomas Duskey (Author), Arianna Rinaldi (Author), Ilaria Ottonelli (Author), Riccardo Caraffi (Author), Chiara Alessia De Benedictis (Author), Ann Katrin Sauer (Author), Giovanni Tosi (Author), Maria Angela Vandelli (Author), Barbara Ruozi (Author), Andreas Martin Grabrucker (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro Evidence
by: Francesca Pederzoli, et al.
Published: (2019) -
Microfluidic Technology for the Production of Hybrid Nanomedicines
by: Ilaria Ottonelli, et al.
Published: (2021) -
Corrigendum to "Quantitative comparison of the protein corona of nanoparticles with different matrices" [Int J Pharm X 2022 Oct 21;4: 100136]
by: Ilaria Ottonelli, et al.
Published: (2023) -
Quantitative comparison of the protein corona of nanoparticles with different matrices
by: Ilaria Ottonelli, et al.
Published: (2022) -
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
by: Natalia Oddone, et al.
Published: (2020)